Vanishing white matter: deregulated integrated stress response as therapy target.
Abbink, Truus E M
Vanishing white matter: deregulated integrated stress response as therapy target. [electronic resource] - Annals of clinical and translational neurology 08 2019 - 1407-1422 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2328-9503
10.1002/acn3.50826 doi
Acetamides--pharmacology
Activating Transcription Factor 4--metabolism
Adaptor Proteins, Signal Transducing--metabolism
Animals
Astrocytes--metabolism
Brain--metabolism
Cell Cycle Proteins--metabolism
Cerebellum--drug effects
Corpus Callosum--drug effects
Cyclohexylamines--pharmacology
Eukaryotic Initiation Factor-2B--genetics
Humans
Leukoencephalopathies--drug therapy
Mice
Mutation
Protein Biosynthesis
Protein Serine-Threonine Kinases--metabolism
White Matter--pathology
Vanishing white matter: deregulated integrated stress response as therapy target. [electronic resource] - Annals of clinical and translational neurology 08 2019 - 1407-1422 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2328-9503
10.1002/acn3.50826 doi
Acetamides--pharmacology
Activating Transcription Factor 4--metabolism
Adaptor Proteins, Signal Transducing--metabolism
Animals
Astrocytes--metabolism
Brain--metabolism
Cell Cycle Proteins--metabolism
Cerebellum--drug effects
Corpus Callosum--drug effects
Cyclohexylamines--pharmacology
Eukaryotic Initiation Factor-2B--genetics
Humans
Leukoencephalopathies--drug therapy
Mice
Mutation
Protein Biosynthesis
Protein Serine-Threonine Kinases--metabolism
White Matter--pathology